Steris Plc (STE) Gross Profit Margin starting from the fourth quarter 2026 to fourth quarter 2025, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket
 


Steris Plc  (NYSE: STE)


Steris Plc's Gross Profit Margin by quarter

Trends, Rankings, Statistics



STE Gross Profit Margin (Mar 31 2026)
Q4
(Dec 31 2025)
Q3
(Sep 30 2025)
Q2
(Jun 30 2025)
Q1
(Mar 31 2025)
Q4
Y / Y Revenue Change 7.28 %
Seq. Revenue Change 6.16 %
Revenue In Millions $1,588.30
Gross Profit Margin 43.89 %
Gross Profit Margin Total Ranking # 1936
Gross Profit In Millions $697.10
Y / Y Gross Profit Change 8.72 %
Seq. Gross Profit Change 6.35 %


Commenting fourth quarter 2026 Gross Profit Margin
Steris Plc Gross Profit grew by 6.35 % in Q4 sequentially to 697 millions, while Revenue increased by 6.16 %, this led to improvement in the company's Gross Profit Margin to 43.89 %, above the Steris Plc average Gross Profit Margin.


Observing fourth quarter 2026 results within Medical Equipment & Supplies industry 132 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin total ranking has impoved so far to 1936, from total ranking in the previous quarter at 2110.
Learn about Gross Margin
STE's Gross Profit Margin fourth quarter 2026 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 133
Healthcare Sector # 339
Overall # 1919

Gross Profit Margin Statistics
High Average Low
49.24 % 42.44 % 37.59 %
(Jun 30 2022)   (Jun 30 2016)




Other Gross Profit Margin Profitability Ratios
STE's Cumulative Gross Profit Margin
Medical Equipment & Supplies Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
STE's Gross Profit Margin Profitability versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for STE's Competitors
Gross Profit Margin Profit Margin for Steris Plc's Suppliers
Gross Profit Margin Profit Margin for STE's Customers

You may also want to know
STE's Annual Growth Rates STE's Profitability Ratios STE's Asset Turnover Ratio STE's Dividend Growth
STE's Roe STE's Valuation Ratios STE's Financial Strength Ratios STE's Gross Profit Growth
STE's Roa STE's Inventory Turnover Ratio STE's Growth Rates STE's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Mar 31 2026, within Medical Equipment & Supplies Industry Gross Profit MarginMar 31 2026 MRQ Gross ProfitMar 31 2026 MRQ Revenue
Soleno Therapeutics Inc  98.73 %$ 93.405  Millions$ 94.603  Millions
Longduoduo Co Ltd  98.24 %$ 0.184  Millions$ 0.187  Millions
Sanara Medtech Inc   96.28 %$ 25.875  Millions$ 26.875  Millions
Solana Company  95.03 %$ 3.441  Millions$ 3.621  Millions
Cvrx inc   92.80 %$ 12.881  Millions$ 13.881  Millions
Seastar Medical Holding Corp  90.71 %$ 0.449  Millions$ 0.495  Millions
Catheter Precision Inc   90.28 %$ 0.390  Millions$ 0.432  Millions
Sight Sciences Inc   89.46 %$ 16.978  Millions$ 18.978  Millions
Electrocore Inc   89.32 %$ 8.364  Millions$ 9.364  Millions
Ceribell Inc   88.52 %$ 23.122  Millions$ 26.122  Millions
Trisalus Life Sciences Inc   88.46 %$ 7.669  Millions$ 8.669  Millions
Nexalin Technology Inc   87.85 %$ 0.013  Millions$ 0.015  Millions
Delcath Systems Inc   87.63 %$ 21.258  Millions$ 24.258  Millions
Inspire Medical Systems inc   86.76 %$ 176.912  Millions$ 203.912  Millions
Neuraxis Inc   86.42 %$ 1.390  Millions$ 1.608  Millions
Electromed Inc   83.00 %$ 14.643  Millions$ 17.643  Millions
Mobia Medical Inc   82.33 %$ 9.941  Millions$ 12.074  Millions
Fonar Corporation  81.94 %$ 21.691  Millions$ 26.472  Millions
Neuropace Inc   81.86 %$ 18.048  Millions$ 22.048  Millions
Vycor Medical Inc   81.81 %$ 0.375  Millions$ 0.459  Millions
Avita Medical Inc   81.70 %$ 15.728  Millions$ 19.251  Millions
Heartflow Inc   80.83 %$ 42.164  Millions$ 52.164  Millions
Axe Compute Inc  80.83 %$ 0.029  Millions$ 0.035  Millions
Si bone inc   80.75 %$ 41.944  Millions$ 51.944  Millions
Carlsmed Inc   80.55 %$ 12.425  Millions$ 15.425  Millions
Pulmonx Corporation  80.04 %$ 16.044  Millions$ 20.044  Millions
Petvivo Holdings Inc   79.78 %$ 0.203  Millions$ 0.255  Millions
Treace Medical Concepts Inc   79.26 %$ 37.407  Millions$ 47.198  Millions
Edwards Lifesciences Corporation  78.03 %$ 1,286.000  Millions$ 1,648.000  Millions
Glaukos Corp  78.03 %$ 117.232  Millions$ 150.232  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.